Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia
Analysis of Road Traffic Accident Claimants Evaluated for Medico-Legal Assessment, Pretoria, South Africa
Mehandru Syndrome, Newly Discovered Class of Pseudohypoaldosteronism (PHA-M), Role of Medication in Addition to Low Potassium Diet